Terms: = Lung cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Treatment
11 results:
1. Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (cd32)-dependent Manner.
Takami M; Aoki T; Nishimura K; Tanaka H; Onodera A; Motohashi S
Cancer Res Commun; 2024 Feb; 4(2):446-459. PubMed ID: 38319156
[TBL] [Abstract] [Full Text] [Related]
2. Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype.
Rojo-Tolosa S; Sánchez-Martínez JA; Pineda-Lancheros LE; Gálvez-Navas JM; González-Gutiérrez MV; Jiménez-Gálvez G; Pérez-Ramírez C; Morales-García C; Jiménez-Morales A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108192
[TBL] [Abstract] [Full Text] [Related]
3. Application of artificial intelligence in the diagnosis of multiple primary lung cancer.
Li X; Hu B; Li H; You B
Thorac Cancer; 2019 Nov; 10(11):2168-2174. PubMed ID: 31529684
[TBL] [Abstract] [Full Text] [Related]
4. A Differential Item Functioning Analysis of the EQ-5D in cancer.
Smith AB; Cocks K; Parry D; Taylor M
Value Health; 2016 Dec; 19(8):1063-1067. PubMed ID: 27987634
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing.
Schrock AB; Frampton GM; Herndon D; Greenbowe JR; Wang K; Lipson D; Yelensky R; Chalmers ZR; Chmielecki J; Elvin JA; Wollner M; Dvir A; -Gutman LS; Bordoni R; Peled N; Braiteh F; Raez L; Erlich R; Ou SH; Mohamed M; Ross JS; Stephens PJ; Ali SM; Miller VA
Clin Cancer Res; 2016 Jul; 22(13):3281-5. PubMed ID: 26933124
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and Molecular Characteristics of NF1-Mutant lung cancer.
Redig AJ; Capelletti M; Dahlberg SE; Sholl LM; Mach S; Fontes C; Shi Y; Chalasani P; Jänne PA
Clin Cancer Res; 2016 Jul; 22(13):3148-56. PubMed ID: 26861459
[TBL] [Abstract] [Full Text] [Related]
7. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O
J BUON; 2013; 18(1):261-7. PubMed ID: 23613414
[TBL] [Abstract] [Full Text] [Related]
8. IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.
Santegoets SJ; Turksma AW; Suhoski MM; Stam AG; Albelda SM; Hooijberg E; Scheper RJ; van den Eertwegh AJ; Gerritsen WR; Powell DJ; June CH; de Gruijl TD
J Transl Med; 2013 Feb; 11():37. PubMed ID: 23402380
[TBL] [Abstract] [Full Text] [Related]
9. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract] [Full Text] [Related]
10. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
Ohwada S; Ikeya T; Yokomori T; Kusaba T; Roppongi T; Takahashi T; Nakamura S; Kakinuma S; Iwazaki S; Ishikawa H; Kawate S; Nakajima T; Morishita Y
Br J Cancer; 2004 Mar; 90(5):1003-10. PubMed ID: 14997197
[TBL] [Abstract] [Full Text] [Related]
11. In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5.
Rivoltini L; Viggiano V; Spinazzè S; Santoro A; Colombo MP; Takatsu K; Parmiani G
Int J Cancer; 1993 Apr; 54(1):8-15. PubMed ID: 8386711
[TBL] [Abstract] [Full Text] [Related]
